Maria Huelsebeck
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
Journal: Journal of medical economics
Published: August 23, 2022
Assessment of the burden of disease for patients with peripheral artery disease undergoing revascularization in England.
Journal: Vascular medicine (London, England)
Published: June 07, 2022
Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies.
Journal: Cardiovascular therapeutics
Published: February 25, 2022
Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis.
Journal: Cardiovascular therapeutics
Published: May 19, 2021
Systematic Literature Review of Randomized Trials Comparing Antithrombotic Therapy Following Revascularization Procedures in Patients With Peripheral Artery Disease.
Journal: Angiology
Published: July 09, 2020
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review.
Journal: Cardiovascular therapeutics
Published: February 28, 2019
Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials.
Journal: Cardiovascular therapeutics
Published: January 23, 2019
Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany - A retrospective cohort study.
Journal: International journal of cardiology. Heart & vasculature
Published: November 07, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026